NIH-funded research NIH-funded research

A two-step approach to boost stem cell therapy for knee osteoarthritis after injury

Official title: An Innovative Two-Step Therapeutic Strategy to Maximize the Effect of Stem Cell Therapy for Post-Traumatic Osteoarthritis

Funded at Memphis VA Medical Center · NIH-11322667 · Data updated 2026-11-12

A new treatment idea uses fat-derived stem cells that are pre-treated to resist inflammation and programmed delivery to improve healing in people with knee osteoarthritis after injury.

More Osteoarthritis research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionMemphis VA Medical Center
NIH-funded
Lab location1 site (Memphis, United States)
Project startApril 1, 2023
Project endMarch 31, 2027
Funding year2026
NIH project number5I01RX004283-04
Project IDNIH-11322667 on NIH RePORTER

Who could benefit from this research

Could help

Adults with post-traumatic knee osteoarthritis or those at risk due to prior knee injuries and inflammatory joint conditions.

Less likely to help

Individuals without PTOA or inflammatory joint disease may not benefit from this specific approach.

What this research studies

This project explores making stem cell therapy safer and more effective for post-traumatic knee OA by pre-treating adipose-derived stem cells with antioxidants and using a specialized delivery system. It builds on a mouse model to test whether pre-treated cells survive better after being injected into the joint and reduce inflammation. The research also investigates a small molecule inhibitor to further reduce inflammatory signals at the joint, aiming to enhance tissue regeneration. If successful, this could move toward clinical testing to help patients with PTOA from prior injuries.

Why it matters

Potential benefit: If successful, this approach could improve joint regeneration and reduce pain for patients with post-traumatic knee OA.

How similar studies have gone: Preclinical studies have shown adipose-derived stem cells can promote regeneration, but translation to effective human therapies with protective pre-treatments remains under investigation.

Where this research is happening

  • Memphis VA Medical Center
    Memphis, United States
    Active

Researchers

  • Principal investigator: Cho, Hongsik Jake — Memphis VA Medical Center
  • Study coordinator: Cho, Hongsik Jake

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.